NASDAQ:NXL

Nexalin Technology Q4 2024 Earnings Results & Report

Nexalin Technology logo
$1.44 -0.06 (-4.00%)
Closing price 11/18/2026 03:58 PM Eastern
Extended Trading
$1.51 +0.07 (+4.86%)
As of 11/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Nexalin Technology reported Q4 2024 earnings on March 14, 2025. The company reported EPS of -$8.40, while revenue was $30 thousand.

Earnings Announcement Details

Quarter
Q4 2024
Report Date
Time
After Market Closes
Conference Call
8:00 AM ET

Nexalin Technology EPS Results

Actual EPS
-$8.40
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A
EPS Beat Rate
2 of last 7 quarters

Nexalin Technology Revenue Results

Actual Revenue
$30 thousand
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Earnings Documents

Nexalin Technology Q4 2024 Earnings FAQ

Nexalin Technology (NASDAQ:NXL) reported earnings of -$8.40 per share for Q4 2024. The report was announced on Friday, March 14, 2025.

Nexalin Technology reported revenue of $30 thousand for Q4 2024.

Nexalin Technology Earnings Headlines

Pentagon magnet restrictions take effect January 1, 2027
A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It would build and operate a rare earth processing facility on an active military base, with the Army receiving first right to production. The timing matters. New Pentagon restrictions on certain Chinese-origin rare earth magnets take effect January 1, 2027, while China controls more than 90% of global rare earth processing. The company's mine-to-magnet platform spans feedstock agreements, processing facilities, metallization technology, and downstream manufacturing, with initial commercial output targeted for 2027.tc pixel
NXL - Nexalin Technology, Inc.
See More Nexalin Technology Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Nexalin Technology? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nexalin Technology and other key companies, straight to your email.

About Nexalin Technology

Nexalin Technology (NASDAQ:NXL) develops non-invasive neurostimulation devices for behavioral health applications. Its technology delivers low-level electrical signals through electrodes placed on the head, with the aim of supporting care for conditions such as anxiety, depression and insomnia.

The company’s product line includes its Gen-2 and Gen-3 cranial electrotherapy stimulation devices. Nexalin focuses on developing and commercializing these systems for use by healthcare providers and patients, and has pursued regulatory clearances and distribution opportunities in the United States and international markets.

View Nexalin Technology Profile